BioSpace News Archive

Sol-Gel Technologies, Ltd. (NASDAQ: SLGL), a clinical-stage dermatology company focused on identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases, today announced an update regarding the U.S. Food and Drug Administration (FDA) approval process for EPSOLAY® (benzoyl peroxide) 5% topical cream for the treatment of Inflammatory lesions of rosacea in adults.

AIkido Pharma Inc. (Nasdaq: AIKI) (“AIkido” or the “Company”) today announced that Dr. Rachel Yehuda appeared at SXSW for a panel discussion entitled Psychedelics: Rewiring Mental Health Care.

AA Pharma, a Canadian company focused on legacy pharmaceutical products, has secured the exclusive Canadian rights for the use of a blood analyzer for patients prescribed Clozapine.

Ultivue, a leader in advancing precision medicine solutions through a unique approach that combines multiplex biomarker analysis with same slide traditional H&E for tissue phenotyping, today announced the completion of a $50 million Series D round of financing.

TAGNOS, an emerging Southern California Medical Technology software company, that empowers hospitals to orchestrate healthcare with increased situational intelligence, workflow optimizations, and improved asset utilization, is excited to announce the appointment of Sheila Minton as its new President and Chief Executive Officer

UBC, a late-stage research and patient-support services organization, and THREAD, a technology and service provider enabling DCTs, today announced UBC’s selection of THREAD to leverage decentralized approaches across studies in the UBC portfolio.

DEFINING CLEAR DEVELOPMENT PATHWAY FOR NEXT GENERATION OF PSYCHEDELIC MEDICINES TO TREAT ADDICTION

Ms. Johns has more than 30 years of experience in the pharmaceutical industry, playing a key role in product development and regulatory strategy in support of numerous marketing applications across a variety of therapeutic fields.

The Melanoma Research Alliance, the largest non-profit funder of melanoma research, is proud to announce $8.1 million in funding for 34 new research awards. The awards, issued near the start of Melanoma Awareness Month, provide critical funding to address urgent unmet needs in melanoma.

Project Lyme, a 5013 focused on eradicating the epidemic of tick-borne diseases, is pleased to announce that on May 1st, 2021, the Helmsley Building, a 35-story structure at 230 Park Avenue between East 45th and 46th streets in Midtown Manhattan will light green in honor of World Lyme Day.